Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine in Erosive Oral Lichen Planus
NCT04442633Completed
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of glutamine in oral lichen planus (OLP) (2 arms). Primary endpoint: Change in oral lichen planus lesions severity at 3 months. Started Apr 2019; status: completed.
02
Drugs
glutamine
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT04442633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04442633.